|
Bioanalytical Focus Group |
 |
The Bioanalytical Focus Group has been in existence since 2000. The group focuses
on chromatographic assays applied to quantitative and qualitative investigations
of small and large molecules in biological matrices that support drug discovery
and development. The modern bioanalytical laboratory utilizes a range of
technologies and techniques which are constantly evolving. This focus group helps
coordinate AAPS supported programming and resources for its membership to help
educate and inform of these developments.
Some specific goals include:
- Coordinate AAPS programming suggestions from the membership to help educate and discuss pertinent bioanalytical topics
- Raise awareness of regulatory developments that apply to appropriate areas of bioanalysis
- Discuss emerging technology developments and applications
- Through web site developments offer information resources pertaining to current bioanalysis articles
- Offer a communication link with focus group membership on bioanalysis topics
Steering Committee Meeting Minutes
June 18, 2008
April 30, 2008
March 19, 2008
February 20, 2008
Workshop Presentations
AAPS Workshop on Current Topics in GLP Bioanalysis: Assay Reproducibility for Incurred Samples—Implications of Crystal City Recommendations
Publications
The AAPS Journal, Volume 9, Number 1 / March, 2007
To view this paper, you must be logged into AAPS Pharmaceutica.
Workshop/conference report—Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays
C. T. Viswanathan1, Surendra Bansal2, Brian Booth3, Anthony J. DeStefano4, Mark J. Rose5, Jeffrey Sailstad6, Vinod P. Shah7, Jerome P. Skelly8 , Patrick G. Swann9 and Russell Weiner10
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Veterinary Medicine (CVM)
May 2001
BP
Guidance for Industry: Bioanalytical Method Validation
To join the Bioanalytical Focus Group, click here.
Back To Top
|
|
|
|
|
|
|
Steering Committee Member
Dr. Mark E. Arnold
Bristol-Myers Squibb, Inc.
Princeton, NJ UNITED STATES |
Steering Committee Member
Brian P. Booth
FDA\CDER\OCPB
Rockville, MD UNITED STATES |
Click here to fill out a focus group membership form.
|
|